are assumed to induce conformational changes, which are the origin of the catalytic activation. At the molecular level, the activation and deactivation mechanisms are unknown, as is the dynamics of NO once in the heme pocket. Using ultrafast time-resolved absorption spectroscopy, we measured the kinetics of NO rebinding to sGC after photodissociation. The main spectral transient in the Soret band does not match the equilibrium difference spectrum of NO-liganded minus unliganded sGC, and the geminate rebinding was found to be monoexponential and ultrafast ( ؍ 7.5 ps), with a relative amplitude close to unity (0.97). These characteristics, so far not observed in other hemoproteins, indicate that NO encounters a high energy barrier for escaping from the heme pocket once the His-Fe 2؉ bond has been cleaved; this bond does not reform before NO recombination. The deactivation of isolated sGC cannot occur by only simple diffusion of NO from the heme; therefore, several allosteric states may be inferred, including a desensitized one, to induce NO release. Thus, besides the structural change leading to activation, a consequence of the decoupling of the proximal histidine may also be to induce a change of the heme pocket distal geometry, which raises the energy barrier for NO escape, optimizing the efficiency of NO trapping. The nonsingle exponential character of the NO picosecond rebinding coexists only with the presence of the protein structure surrounding the heme, and the single exponential rate observed in sGC is very likely to be due to a closed conformation of the heme pocket. Our results emphasize the physiological importance of NO geminate recombination in hemoproteins like nitric-oxide synthase and sGC and show that the protein structure controls NO dynamics in a manner adapted to their function. This control of ligand dynamics provides a regulation at molecular level in the function of these enzymes.Guanylate cyclase is involved in signal transduction pathways in which cGMP 1 acts as a second messenger in several types of cells (for reviews, see Refs. 1-4). In endothelial cells, sGC is activated by NO produced by the constitutive enzyme nitric-oxide synthase. The binding of NO induces a several hundred-fold increase of the sGC catalytic activity, leading to cGMP production from GTP. This heterodimeric enzyme possesses a heme in the -subunit where NO binding takes place, while the ␣-subunit harbors the catalytic site, which binds the precursor substrate GTP. The second messenger cGMP then triggers the downstream events leading to smooth muscle relaxation.Regarding diatomic ligand binding, sGC differs from other hemoproteins like myoglobin or hemoglobin; while sGC displays a very high affinity for NO, its affinity for O 2 is very low, but the structural features giving rise to this property are unknown. As in Hb and Mb, the heme iron of sGC is bound to a His side chain (5, 6) but much more weakly. Upon binding of NO to the heme, the His-Fe 2ϩ bond is cleaved, as reflected by the change in Soret absorption posi...